Severe Hypocalcemia Due to Skeletal Remineralization After Venetoclax, Bortezomib, and Dexamethasone for Relapsed Multiple Myeloma

Ann Pharmacother. 2022 Sep;56(9):1076-1078. doi: 10.1177/10600280211062626. Epub 2022 Jan 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Bortezomib / adverse effects
  • Bridged Bicyclo Compounds, Heterocyclic
  • Dexamethasone / adverse effects
  • Humans
  • Hypocalcemia* / chemically induced
  • Hypocalcemia* / drug therapy
  • Multiple Myeloma* / drug therapy
  • Neoplasm Recurrence, Local / drug therapy
  • Sulfonamides

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Bortezomib
  • Dexamethasone
  • venetoclax